STOCK TITAN

Oppenheimer Holdings (OPY) Financials

OPY NYSE
Trailing 12 months to September 30, 2026
Revenue $1.8B +13.9% YoY
Net Income $86.6M +2.2% YoY
EPS (Diluted) $7.43 -0.3% YoY
Free Cash Flow $57.4M -27.5% YoY
Market Cap $885.8M as of Nov 20, 2026
Price / Sales 0.5x on $1.8B revenue, trailing 12 months to September 30, 2026
Price / Earnings 10.2x on $86.6M net income, trailing 12 months to September 30, 2026
Price / Book 0.9x on $991.1M equity, Q3 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Nov 20, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Sep 30, 2026 Reported Currency USD FYE December

Newest figures come from the 10-Q for Q3 FY2026, filed Oct 30, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the OPY SEC filings page.

Oppenheimer Holdings, Inc. (OPY) reported $1.8B in revenue over the twelve months to Sep 30, 2026, up 13.9% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI OPY FY2025

FY2025 shows a business where earnings recovery translated into cash, while margins expanded faster than revenue.

The key shift is cash conversion: operating cash flow moved from -$108M in FY2024 to $189M in FY2025, reversing the prior year’s disconnect between reported profit and cash generation. FY2025 operating cash flow exceeded net income of $148M, producing an operating-cash-flow-to-net-income ratio of 127.2% and indicating that the latest profit improvement was broadly realized in cash.

Revenue increased 14.4% in FY2025, but operating income increased 99.7%. This gap indicates that the recovery was driven more by improved profitability per revenue dollar than by top-line growth alone.

Capital expenditures were only 0.3% of revenue, while liabilities represented 73.2% of assets in FY2025. That combination describes a business needing little physical reinvestment but carrying a liability-heavy balance sheet, so its economics depend less on funding factories and more on managing its financial structure.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Earnings Growth Capital Efficiency CreditQuality Stability 72 / 100
Financial Health Score (4 of 6 dimensions) 72/100
Scored as: Banks peer group

Scored against banks for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed: here 4 of 6, with the others left out rather than counted as zero. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Oppenheimer Holdings, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Earnings
97

Earnings ranks banks on their return on assets, the profit made on every dollar of assets on the books, averaged over the last three fiscal years with the newest weighted most. Oppenheimer Holdings, Inc. scores 97/100 on it among other banks.

Growth
74

Growth ranks banks on the yearly rate at which their net revenue, which is interest income and fee income less the interest they pay out, compounded across the last three fiscal years (the last two where the earliest reports none), counted in the currency each bank reports in. Oppenheimer Holdings, Inc. scores 74/100 on it among other banks.

Capital
95

Oppenheimer Holdings, Inc. funded 26.4% of its assets with shareholders' equity at the end of fiscal year 2025, holding $983.8M of equity against $3.7B of assets. Capital ranks banks on that cushion, and Oppenheimer Holdings, Inc. scores 95/100 among other banks.

Efficiency
n/a

Not available for Oppenheimer Holdings, Inc., so it is left out of the overall score, which averages the 4 of 6 dimensions that can be computed.

Credit Quality
n/a

Not available for Oppenheimer Holdings, Inc., so it is left out of the overall score, which averages the 4 of 6 dimensions that can be computed.

Stability
21

Stability ranks banks on how far their net income strayed from its own average over the last five fiscal years, measured against the size of that average, and a smaller spread ranks higher. Oppenheimer Holdings, Inc. scores 21/100 on it among other banks.

Piotroski F-Score Partial
5/6

Oppenheimer Holdings, Inc. passes 5 of 6 computable financial strength tests (3 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), the one computable operating efficiency signal (asset turnover improving) passes.

Interest Coverage Adequate
2.44x

Oppenheimer Holdings, Inc. earns $2.44 in operating income for every $1 of interest expense ($211.2M vs $86.6M). This adequate coverage means the company can meet its interest obligations, but has limited cushion if earnings fall.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$382.0M
YoY-10.0%
QoQ-16.0%
5Y CAGR+3.9%
10Y CAGR+6.1%

Oppenheimer Holdings, Inc. generated $382.0M in revenue in Q3 2026. This represents a decrease of 10.0% from the same quarter a year earlier. Against the prior quarter it is down 16.0%.

Net Income
$5.5M
YoY-74.9%
QoQ-80.0%
5Y CAGR-27.0%
10Y CAGRn/m

Oppenheimer Holdings, Inc. reported $5.5M in net income in Q3 2026. This represents a decrease of 74.9% from the same quarter a year earlier. Against the prior quarter it is down 80.0%.

EPS (Diluted)
$0.47
YoY-75.3%
QoQ-80.3%
5Y CAGR-24.5%
10Y CAGRn/m

Oppenheimer Holdings, Inc. earned $0.47 per diluted share (EPS) in Q3 2026. This represents a decrease of 75.3% from the same quarter a year earlier. Against the prior quarter it is down 80.3%.

EBITDA

Not reported for Q3 2026.

Cash & Balance Sheet

Free Cash Flow
$128.6M
YoY+106.7%
QoQn/m

Oppenheimer Holdings, Inc. generated $128.6M in free cash flow in Q3 2026, representing cash available after capex. This represents an increase of 106.7% from the same quarter a year earlier. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

Cash & Debt
$38.0M
YoY-0.7%
QoQ-1.2%
5Y CAGR-23.0%
10Y CAGR-9.1%

Oppenheimer Holdings, Inc. held $38.0M in cash as of Q3 2026; no long-term debt figure is on record for that period.

Dividends Per Share
$0.20
YoY+11.1%
QoQ0.0%
5Y CAGR+5.9%
10Y CAGR+6.2%

Oppenheimer Holdings, Inc. paid $0.20 per share in dividends in Q3 2026. This represents an increase of 11.1% from the same quarter a year earlier. It is unchanged from the prior quarter.

Shares Outstanding
11M
YoY+1.8%
QoQ0.0%
5Y CAGR-3.2%
10Y CAGR-2.2%

Oppenheimer Holdings, Inc. had 11M shares outstanding in Q3 2026. This represents an increase of 1.8% from the same quarter a year earlier. It is unchanged from the prior quarter.

Margins & Returns

Operating Margin
2.3%
YoY-5.1pp
QoQ-6.4pp
5Y change-9.6pp

Oppenheimer Holdings, Inc.'s operating margin was 2.3% in Q3 2026, reflecting core business profitability. This is down 5.1 percentage points from the same quarter a year earlier. Against the prior quarter it is down 6.4 percentage points.

Net Margin
1.4%
YoY-3.7pp
QoQ-4.6pp
5Y change-6.9pp
10Y change+1.8pp

Oppenheimer Holdings, Inc.'s net profit margin was 1.4% in Q3 2026, showing the share of revenue converted to profit. This is down 3.7 percentage points from the same quarter a year earlier. Against the prior quarter it is down 4.6 percentage points.

Return on Equity
0.5%
YoY-1.8pp
QoQ-2.2pp
5Y change-2.8pp
10Y change+0.7pp

Oppenheimer Holdings, Inc.'s quarterly ROE was 0.5% in Q3 2026: one quarter's net income over shareholder equity, not annualized. This is down 1.8 percentage points from the same quarter a year earlier. Against the prior quarter it is down 2.2 percentage points.

Gross Margin

Not reported for Q3 2026.

Capital Allocation

Share Buybacks
$0
YoYn/m
QoQn/m

Oppenheimer Holdings, Inc. repurchased no shares in Q3 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

Capital Expenditures
$3.8M
YoY+211.4%
QoQ+85.0%

Oppenheimer Holdings, Inc. invested $3.8M in capex in Q3 2026, funding long-term assets and infrastructure. This represents an increase of 211.4% from the same quarter a year earlier. Against the prior quarter it is up 85.0%.

R&D Spending

Not reported for Q3 2026.

OPY Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

OPY quarterly income statement
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Revenue$382.0M-10.0%$454.9M+21.9%$445.1M+21.0%$472.6M+25.9%$424.4M+13.7%$373.2M+12.9%$367.8M+4.2%$375.4M+21.8%
Operating Income$8.8M-72.2%$39.4M+22.5%-$27.0M-165.3%$106.0M+520.9%$31.6M-10.6%$32.2M+103.0%$41.4M+10.5%$17.1M-4.3%
Interest Expense$21.7M-3.4%$19.9M-11.7%$18.7M-12.7%$20.1M-5.7%$22.5M-6.7%$22.5M+2.5%$21.4M+4.1%$21.4M+17.1%
Income Tax$3.4M-65.9%$12.1M+14.8%-$6.4M-160.0%$32.1M+405.7%$9.9M-8.6%$10.5M+88.2%$10.7M-8.5%$6.3M+1.6%
Net Income$5.5M-74.9%$27.4M+26.2%-$20.6M-167.1%$74.4M+593.1%$21.7M-11.4%$21.7M+111.1%$30.7M+17.7%$10.7M-3.4%
EPS (Basic)$0.52-74.8%$2.55+23.8%-$1.93-165.9%$7.08+580.8%$2.06-13.4%$2.06+108.1%$2.93+17.2%$1.04-1.9%
EPS (Diluted)$0.47-75.3%$2.38+24.6%-$1.93-171.0%$6.51+607.6%$1.90-12.0%$1.91+107.6%$2.72+14.8%$0.92-5.2%
Diluted Shares (Avg)12M+1.2%11M+1.2%11M-5.6%N/A11M+1.5%11M+2.1%11M+2.5%N/A

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, EBITDA.

OPY Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

OPY quarterly balance sheet
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Total Assets$4.1B+7.1%$4.2B+14.7%$3.8B+6.8%$3.7B+10.0%$3.8B+13.4%$3.7B+13.0%$3.6B+9.8%$3.4B+17.7%
Cash & Equivalents$38.0M-0.7%$38.5M+2.2%$34.6M-5.7%$38.4M+15.9%$38.3M+18.8%$37.6M+13.3%$36.7M+32.7%$33.1M+15.0%
Goodwill$143.6M0.0%$143.6M0.0%$143.6M0.0%$143.6M0.0%$143.6M+1.0%$143.6M+1.0%$143.6M+1.0%$143.6M+1.0%
Total Liabilities$3.1B+6.4%$3.2B+15.9%$2.8B+5.5%$2.7B+7.6%$2.9B+14.6%$2.8B+13.9%$2.7B+10.2%$2.5B+21.4%
Long-Term DebtN/AN/AN/AN/AN/AN/AN/A$0-100.0%
Total Equity$991.1M+7.7%$983.4M+9.7%$952.4M+9.2%$983.8M+15.7%$920.3M+9.8%$896.9M+10.4%$872.3M+8.8%$850.4M+7.8%
Retained Earnings$953.4M+7.4%$950.1M+9.5%$924.9M+9.0%$947.4M+15.5%$887.7M+9.4%$867.9M+10.0%$848.7M+8.7%$820.0M+8.4%

Not reported in any period shown, so not listed: Current Assets, Short-Term Investments, Inventory, Accounts Receivable, Long-Term Investments, Current Liabilities, Non-Current Liabilities.

OPY Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

OPY quarterly cash flow statement
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Operating Cash Flow$132.4M+108.7%-$55.0M-237.3%-$190.0Mn/m$177.0M+136.9%$63.4M+454.7%$40.1Mn/m-$91.7Mn/m$74.7M+14.2%
Stock-Based CompensationN/AN/A$26.2M+3564.4%N/AN/AN/A$716K-58.8%N/A
Capital Expenditures$3.8M+211.4%$2.0M+80.1%$0-100.0%$1.2M-63.8%$1.2M+448.2%$1.1M-20.0%$1.7M+551.6%$3.3M-28.9%
Free Cash Flow$128.6M+106.7%-$57.1M-246.5%-$190.0Mn/m$175.8M+146.1%$62.2M+454.8%$38.9Mn/m-$93.4Mn/m$71.5M+17.5%
Investing Cash Flow-$3.1M-577.4%-$981Kn/m$549Kn/m-$770Kn/m$641K-65.7%-$900Kn/m-$359Kn/m-$4.3Mn/m
Financing Cash Flow-$129.7Mn/m$59.9Mn/m$185.6M+94.1%-$176.1Mn/m-$63.4Mn/m-$38.2M-131.4%$95.6M+22.4%-$69.5Mn/m
Dividends Paid$2.1M+13.0%$2.1M+13.2%$12.4M+555.1%$1.9M+1.8%$1.9M+1.8%$1.9M+22.2%$1.9M+20.2%$1.9M+20.2%
Share Buybacks$0n/m$0-100.0%$0-100.0%$2.3Mn/m$0-100.0%$581K-37.2%$90K-98.9%$0-100.0%

Not reported in any period shown, so not listed: Depreciation & Amortization.

OPY Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

OPY quarterly financial ratios
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Operating Margin2.3%-5.1pp8.7%0.0pp-6.1%-17.3pp22.4%+17.9pp7.4%-2.0pp8.6%+3.8pp11.3%+0.6pp4.5%-1.2pp
Net Margin1.4%-3.7pp6.0%+0.2pp-4.6%-13.0pp15.7%+12.9pp5.1%-1.4pp5.8%+2.7pp8.3%+0.9pp2.9%-0.7pp
Return on Equity0.5%-1.8pp2.8%+0.4pp-2.2%-5.7pp7.6%+6.3pp2.4%-0.6pp2.4%+1.2pp3.5%+0.3pp1.3%-0.1pp
Return on Assets0.1%-0.4pp0.7%+0.1pp-0.5%-1.4pp2.0%+1.7pp0.6%-0.2pp0.6%+0.3pp0.9%+0.1pp0.3%-0.1pp
Debt-to-EquityN/AN/AN/AN/AN/AN/AN/A0.00-0.1x
Liabilities-to-Equity3.110.0x3.29+0.2x2.99-0.1x2.77-0.2x3.15+0.1x3.11+0.1x3.100.0x2.98+0.3x
Asset Turnover0.090.0x0.110.0x0.120.0x0.130.0x0.110.0x0.100.0x0.100.0x0.110.0x
FCF Margin33.7%+19.0pp-12.5%-23.0pp-42.7%-17.3pp37.2%+18.2pp14.7%+11.7pp10.4%+45.7pp-25.4%-2.9pp19.0%-0.7pp

Not reported in any period shown, so not listed: Gross Margin, Current Ratio.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Oppenheimer Holdings, Inc. OPY FY2025 $1.6B $148.4M 9.1% $885.8M 72/100
Perella Weinberg Partners PWP FY2025 $750.9M $35.5M 4.7% $953.6M 15/100
Sharplink, Inc. SBET FY2025 $28.1M -$734.6M N/A $973.7M 71/100
Gold.com, Inc. GOLD FY2026 $25.5B $82.3M 0.3% $1.1B 61/100
UP Fintech Holding Ltd TIGR FY2025 $538.7M $171.4M 31.8% $660.0M 59/100
CleanSpark Inc CLSK FY2026 N/A N/A N/A $1.3B —

Frequently Asked Questions

Oppenheimer Holdings, Inc. (OPY) reported $1.6B in total revenue for fiscal year 2025. This represents a 14.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Oppenheimer Holdings, Inc. (OPY) revenue grew by 14.4% year-over-year, from $1.4B to $1.6B in fiscal year 2025.

Yes, Oppenheimer Holdings, Inc. (OPY) reported a net income of $86.6M over the trailing 12 months to September 30, 2026. In fiscal year 2025 it reported a net income of $148.4M, with a net profit margin of 9.1%.

Oppenheimer Holdings, Inc. (OPY) reported diluted earnings per share of $13.04 for fiscal year 2025. This represents a 104.7% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Oppenheimer Holdings, Inc. (OPY) had EBITDA of $222.2M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

Oppenheimer Holdings, Inc. (OPY) had an operating margin of 12.9% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Oppenheimer Holdings, Inc. (OPY) had a net profit margin of 9.1% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Yes, Oppenheimer Holdings, Inc. (OPY) paid $1.72 per share in dividends during fiscal year 2025.

Oppenheimer Holdings, Inc. (OPY) has a return on equity of 15.1% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Oppenheimer Holdings, Inc. (OPY) generated $183.6M in free cash flow during fiscal year 2025. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Oppenheimer Holdings, Inc. (OPY) generated $188.8M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Oppenheimer Holdings, Inc. (OPY) had $3.7B in total assets as of fiscal year 2025, including both current and long-term assets.

Oppenheimer Holdings, Inc. (OPY) invested $5.2M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Yes, Oppenheimer Holdings, Inc. (OPY) spent $3.0M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Oppenheimer Holdings, Inc. (OPY) had 11M shares outstanding as of fiscal year 2025.

Oppenheimer Holdings, Inc. (OPY) had a liabilities-to-equity ratio of 2.77 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity. No debt-to-equity ratio is shown for fiscal year 2025, because the filing data we hold for that year carries no long-term debt figure.

Oppenheimer Holdings, Inc. (OPY) had a return on assets of 4.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Oppenheimer Holdings, Inc. (OPY) trades at 10.2x earnings, its market capitalization divided by $86.6M net income, trailing 12 months to September 30, 2026. The market capitalization is $885.8M as of Nov 20, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Oppenheimer Holdings, Inc. (OPY) trades at 0.5x sales, its market capitalization divided by $1.8B revenue, trailing 12 months to September 30, 2026. The market capitalization is $885.8M as of Nov 20, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Oppenheimer Holdings, Inc. (OPY) has a Piotroski F-Score of 5 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Oppenheimer Holdings, Inc. (OPY) has an interest coverage ratio of 2.44x, meaning it can adequately cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Oppenheimer Holdings, Inc. (OPY) scores 72 out of 100 on our Financial Health Score, indicating strong standing within its banks peer group. The score is the average of six dimensions (Earnings, Growth, Capital, Efficiency, Credit Quality, Stability), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. For Oppenheimer Holdings, Inc. it averages the 4 of 6 dimensions that can be computed; the others are left out rather than counted as zero. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top